News
Career
Become a Client
Become a Client
or call +6569836140
+447466543519

A New Era in Brain Cancer Treatment: GD2-CAR T Cell Therapy Shows Promise for Hard-to-Treat Gliomas

Read more ➔

TOP STORIES

1.
Cell and Gene Therapy

A New Era in Brain Cancer Treatment: GD2-CAR T Cell Therapy Shows Promise for Hard-to-Treat Gliomas

2.
Cell and Gene Therapy

Capsida Biotherapeutics’ CAP-003 Gene Therapy Shows Promise for Disease Modification in Parkinson’s Disease with GBA Mutations

3.
Vaccine

Pfizer and BioNTech Report Phase 3 Trial Results on Combination mRNA Vaccine for COVID-19 and Influenza

4.
Cell and Gene Therapy

A New Beginning: Kendric Cromer’s Journey with Gene Therapy for Sickle Cell Disease

5.
Biologics

GSK Reports Successful Phase III Results for Depemokimab in Treating Chronic Rhinosinusitis with Nasal Polyps

THE LATEST

Cell and Gene Therapy

A New Era in Brain Cancer Treatment: GD2-CAR T Cell Therapy Shows Promise for Hard-to-Treat Gliomas

Updated November. 14. 2024
Updated November. 14. 2024

A New Era in Brain Cancer Treatment: GD2-CAR T Cell Therapy Shows Promise for Hard-to-Treat Gliomas

Cell and Gene Therapy
Cell and Gene Therapy

Capsida Biotherapeutics’ CAP-003 Gene Therapy Shows Promise for Disease Modification in Parkinson’s Disease with GBA Mutations

Cell and Gene Therapy
Cell and Gene Therapy

Pfizer and BioNTech Report Phase 3 Trial Results on Combination mRNA Vaccine for COVID-19 and Influenza

Vaccine
Vaccine

A New Beginning: Kendric Cromer’s Journey with Gene Therapy for Sickle Cell Disease

Cell and Gene Therapy
Cell and Gene Therapy

GSK Reports Successful Phase III Results for Depemokimab in Treating Chronic Rhinosinusitis with Nasal Polyps

Biologics
Biologics

New Mechanisms of 5-Fluorouracil in Colon Cancer Treatment: Shifting the Focus from DNA to RNA

Biologics
Biologics

NUHS’s CD7 CAR-T Cell Therapy Shows Breakthrough Promise for Leukaemia

Cell and Gene Therapy
Cell and Gene Therapy

Governments Make Significant Progress in Negotiations for Global Pandemic Preparedness Agreement

World News
World News

Patients Begin Receiving Vertex-CRISPR and Bluebird Bio’s Sickle Cell Gene Therapies

Cell and Gene Therapy
Cell and Gene Therapy

WHO Approves First Mpox Vaccine for Broader Use, Aims to Contain Outbreak in Africa

VaccineWorld News
VaccineWorld News

Aurora Biosynthetics Launches to Revolutionize RNA Therapeutics Manufacturing

World News
World News

Trinity College Dublin Develops Promising Gene Therapy for Glaucoma

Cell and Gene Therapy
Cell and Gene Therapy

Early Onset of Protection with TAK-003 Dengue Vaccine: Insights from the DEN-301 Trial

Vaccine
Vaccine

Revolutionizing RNA Therapeutics: A Novel Pathway to Selective Translation Repression

Cell and Gene Therapy
Cell and Gene Therapy

Acepodia and Pfizer Team Up to Propel Development of Novel Cell Therapies for Autoimmune Diseases

Cell and Gene Therapy
Cell and Gene Therapy

Breakthrough Bacterial Nanovaccine Offers New Hope in Cancer Treatment

Vaccine
Vaccine

Asia’s Largest Cell & Gene Therapy Summit: A Premier Event for R&D, Manufacturing, and Supply Chain

Cell and Gene Therapy
Cell and Gene Therapy

The One & Only Biologics CMO Gathering In Asia

Biologistics
Biologistics

Lonza Secures $30 Million for UK Biologics Site Expansion

Biologics
Biologics

Kyowa Kirin’s New Biologics Manufacturing Plant: A Leap into Advanced Biologics Production

Biologics
Biologics

Innovative Approaches to Combat RSV: Efforts by Georgia State University and Institute for Biomedical Sciences

Vaccine
Vaccine

Get the free newsletter

Subscribe to IMAPAC for top news, trends & analysis

IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.

© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.

ABOUT IMAPAC

About Us

Newsletter

Newsroom

OUR SERVICES

Biopharma Conferences

Market Intelligence

Digital Advertising

GET IN TOUCH

Contact Us

Become A Client

Careers

FOLLOW US ON

Linkedin Facebook Youtube Twitter

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.